Georg Aue, Margaret A. Lindorfer, Paul V. Beum, Andrew W. Pawluczkowycz, Berengere Vire, Thomas Hughes, Ronald P. Taylor and Adrian Wiestner (2010) “Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia”, Haematologica. Pavia, Italy, 95(2), pp. 329-332. doi: 10.3324/haematol.2009.012484.